[Oral contraceptives and blood platelets].
Davenas
E
E
Ciavatti
M
M
Poitevin
B
B
Aubin
M
M
D001695:Biology; D001769:Blood; D001777:Blood Coagulation; D002319:Cardiovascular System; D002560:Cerebrovascular Circulation; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D004194:Disease; D004467:Economics; D005193:Family Planning Services; D066298:In Vitro Techniques; D008055:Lipids; D008660:Metabolism; D009930:Organic Chemicals; D010827:Physiology; D010974:Platelet Aggregation; D012106:Research; D013672:Technology; D013923:Thromboembolism; D013927:Thrombosis; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D008055:Lipids; D009930:Organic Chemicals; D002784:Cholesterol
Biology; Blood Coagulation Effects; Cardiovascular Effects; Cerebrovascular Effects; Cholesterol; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Diseases; Economic Factors; Family Planning; Hematological Effects; Hemic System; In Vitro; Ingredients And Chemicals; Lipid Metabolic Effects; Lipids; Metabolic Effects; Oral Contraceptives; Oral Contraceptives, Combined; Organic Chemicals; Physiology; Platelet Aggregation; Research And Development; Research Methodology; Technology; Thromboembolism; Thrombosis; Vascular Diseases